Filana Therapeutics, Inc. (FLNA): Weighted Average Diluted Shares
48.30M
Year ended 2025-12-31
+6.3%
3-year compound annual growth
+0.5%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 48.30M | +3.6% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | 46.60M | +11.1% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | 41.93M | +4.3% | 2026-03-12, From 2023-01-01 |
| 2022-12-31 | 40.20M | n/a | 2025-03-03, From 2022-01-01 |
| No annual figure between 2015-12-31 and 2022-12-31. | |||
| 2015-12-31 | 45.76M | +1.1% | 2016-03-03, From 2015-01-01 |
| 2014-12-31 | 45.27M | +0.1% | 2016-03-03, From 2014-01-01 |
| 2013-12-31 | 45.21M | +1.0% | 2016-03-03, From 2013-01-01 |
| 2012-12-31 | 44.75M | +1.3% | 2015-02-18, From 2012-01-01 |
| 2011-12-31 | 44.16M | n/a | 2014-02-05, From 2011-01-01 |